We are raising our fair value estimate for Intuitive to $265 per share from $253 due to continuing robust US procedure growth. Shares are expensive at current levels. Our wide moat rating is unchanged.
Intuitive launched its next-generation platform, which should give significant momentum to system placements in the next few years.
We may be seeing the emergence of some competition, particularly for lower-cost procedures.
|
Metric
|
ISRG
|
JNJ
|
MDT
|
|---|---|---|---|
Price/Earnings (Normalized) | 68.89 | 15.23 | 15.11 |
Price/Book Value | 10.55 | 5.37 | 2.06 |
Price/Sales | 20.73 | 4.53 | 3.23 |
Price/Cash Flow | 54.22 | 17.23 | 14.40 |
|
Metric
|
ISRG
|
JNJ
|
MDT
|
|---|---|---|---|
Quick Ratio | 4.03 | 0.77 | 1.31 |
Current Ratio | 5.15 | 1.07 | 2.03 |
Interest Coverage | — | 24.45 | 7.73 |
|
Metric
|
ISRG
|
JNJ
|
MDT
|
|---|---|---|---|
Return on Assets (Normalized) | 14.89% | 13.17% | 7.64% |
Return on Equity (Normalized) | 17.17% | 32.42% | 13.51% |
Return on Invested Capital (Normalized) | 15.09% | 20.93% | 9.78% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Becton Dickinson & Co
BDX
| Xjcymhs | Jbzhrq | $68.6 Bil | |||
| Alcon Inc
ALC
| Prmpncznh | Rbstkbb | $46.5 Bil | |||
| Coloplast A/S ADR
CLPBY
| Ycyldnhdqx | Gbj | $29.1 Bil | |||
| ResMed Inc
RMD
| Rgkzwwprw | Vmwmp | $28.9 Bil | |||
| West Pharmaceutical Services Inc
WST
| Ywjlynwsj | Vzcm | $20.2 Bil | |||
| The Cooper Companies Inc
COO
| Mzgfwvyt | Skmqps | $18.5 Bil | |||
| Hologic Inc
HOLX
| Rflpsjvl | Mfwtpy | $18.2 Bil | |||
| Baxter International Inc
BAX
| Fqwsxdhf | Qmpqc | $18.1 Bil | |||
| Teleflex Inc
TFX
| Tkws | Nlwhl | $10.4 Bil |
